Unknown

Dataset Information

0

Mycobacterial codon optimization enhances antigen expression and virus-specific immune responses in recombinant Mycobacterium bovis bacille Calmette-Guerin expressing human immunodeficiency virus type 1 Gag.


ABSTRACT: Although its potential for vaccine development is already known, the introduction of recombinant human immunodeficiency virus (HIV) genes to Mycobacterium bovis bacille Calmette-Guérin (BCG) has thus far elicited only limited responses. In order to improve the expression levels, we optimized the codon usage of the HIV type 1 (HIV-1) p24 antigen gene of gag (p24 gag) and established a codon-optimized recombinant BCG (rBCG)-p24 Gag which expressed a 40-fold-higher level of p24 Gag than did that of nonoptimized rBCG-p24 Gag. Inoculation of mice with the codon-optimized rBCG-p24 Gag elicited effective immunity, as evidenced by virus-specific lymphocyte proliferation, gamma interferon ELISPOT cell induction, and antibody production. In contrast, inoculation of animals with the nonoptimized rBCG-p24 Gag induced only low levels of immune responses. Furthermore, a dose as small as 0.01 mg of the codon-optimized rBCG per animal proved capable of eliciting immune responses, suggesting that even low doses of a codon-optimized rBCG-based vaccine could effectively elicit HIV-1-specific immune responses.

SUBMITTER: Kanekiyo M 

PROVIDER: S-EPMC1168777 | biostudies-literature | 2005 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mycobacterial codon optimization enhances antigen expression and virus-specific immune responses in recombinant Mycobacterium bovis bacille Calmette-Guérin expressing human immunodeficiency virus type 1 Gag.

Kanekiyo Masaru M   Matsuo Kazuhiro K   Hamatake Makiko M   Hamano Takaichi T   Ohsu Takeaki T   Matsumoto Sohkichi S   Yamada Takeshi T   Yamazaki Shudo S   Hasegawa Atsuhiko A   Yamamoto Naoki N   Honda Mitsuo M  

Journal of virology 20050701 14


Although its potential for vaccine development is already known, the introduction of recombinant human immunodeficiency virus (HIV) genes to Mycobacterium bovis bacille Calmette-Guérin (BCG) has thus far elicited only limited responses. In order to improve the expression levels, we optimized the codon usage of the HIV type 1 (HIV-1) p24 antigen gene of gag (p24 gag) and established a codon-optimized recombinant BCG (rBCG)-p24 Gag which expressed a 40-fold-higher level of p24 Gag than did that of  ...[more]

Similar Datasets

| S-EPMC2808266 | biostudies-literature
| S-EPMC10627825 | biostudies-literature
| S-EPMC5056730 | biostudies-literature
| S-EPMC3295601 | biostudies-literature
| S-EPMC6264175 | biostudies-literature
| S-EPMC3146779 | biostudies-literature
| S-EPMC5807593 | biostudies-literature
| S-EPMC4708234 | biostudies-literature
| S-EPMC7803645 | biostudies-literature
| S-EPMC5536119 | biostudies-literature